| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 1.3.1.9 | medicine | the enzyme is a target for development of anti-tuberculosis drugs | Mycobacterium tuberculosis |
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.3.1.9 | (2E)-1-[4-(1H-pyrrol-1-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-en-1-one | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | (2E)-3-(4-methoxyphenyl)-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | (2E)-3-(4-methylphenyl)-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | (2E)-3-(6-fluorocyclohexa-1,5-dien-1-yl)-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | (2E)-3-[(4Z)-4-ethylidenecyclohexa-1,5-dien-1-yl]-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(4-chlorophenoxy)-5-(1H-1,2,3-triazol-1-yl)phenol | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(4-chlorophenoxy)-5-cyclohexylphenol | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(4-chlorophenoxy)-5-hexylphenol | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(4-chlorophenoxy)-5-[4-(1H-1,2,3-triazol-1-yl)butyl]phenol | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(6-chloro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-phenylacetamide | 88.12% inhibition at 0.01 mM | Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(6-chloro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-[(furan-2-yl)methyl]acetamide | 78.12% inhibition at 0.01 mM | Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(6-chloro-4-oxoquinazolin-3(4H)-yl)-N-phenylacetamide | 58.34% inhibition at 0.01 mM | Mycobacterium tuberculosis | |
| 1.3.1.9 | 2-(6-chloro-4-oxoquinazolin-3(4H)-yl)-N-[2-chloro-5-(trifluoromethyl)phenyl]acetamide | 80.12% inhibition at 0.01 mM | Mycobacterium tuberculosis | |
| 1.3.1.9 | 3-[(2E)-2-benzylidenehydrazinyl]-N-(2,4-dichlorophenyl)-1,2,4-thiadiazol-5-amine | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 3-[(2E)-2-benzylidenehydrazinyl]-N-(4-bromophenyl)-1,2,4-thiadiazol-5-amine | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 3-[(2E)-2-benzylidenehydrazinyl]-N-(4-methoxyphenyl)-1,2,4-thiadiazol-5-amine | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 3-[(2E)-2-[(4-methylphenyl)methylidene]hydrazinyl]-N-phenyl-1,2,4-thiadiazol-5-amine | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 4-(4-chlorophenoxy)-3-hydroxybenzonitrile | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | 4-(4-chlorophenoxy)[1,1'-biphenyl]-3-ol | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | Ethionamide | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | isoniazid | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | N-(4-bromophenyl)-3-{(2E)-2-[(4-methylphenyl)methylidene]hydrazinyl}-1,2,4-thiadiazol-5-amine | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | N-(6-nitro-1,3-benzothiazol-2-yl)-2-(4-oxoquinazolin-3(4H)-yl)acetamide | 72.18% inhibition at 0.01 mM | Mycobacterium tuberculosis | |
| 1.3.1.9 | prothionamide | - |
Mycobacterium tuberculosis | |
| 1.3.1.9 | triclosan | - |
Mycobacterium tuberculosis |
| EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.3.1.9 | trans-DELTA2-enoyl-[acyl-carrier protein] + NADH + H+ | Mycobacterium tuberculosis | - |
acyl-[acyl-carrier protein] + NAD+ | - |
? | |
| 1.3.1.9 | trans-DELTA2-enoyl-[acyl-carrier protein] + NADH + H+ | Mycobacterium tuberculosis H37Rv | - |
acyl-[acyl-carrier protein] + NAD+ | - |
? |
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.3.1.9 | Mycobacterium tuberculosis | P9WGR1 | - |
- |
| 1.3.1.9 | Mycobacterium tuberculosis H37Rv | P9WGR1 | - |
- |
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 1.3.1.9 | trans-DELTA2-enoyl-[acyl-carrier protein] + NADH + H+ | - |
Mycobacterium tuberculosis | acyl-[acyl-carrier protein] + NAD+ | - |
? | |
| 1.3.1.9 | trans-DELTA2-enoyl-[acyl-carrier protein] + NADH + H+ | - |
Mycobacterium tuberculosis H37Rv | acyl-[acyl-carrier protein] + NAD+ | - |
? |
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 1.3.1.9 | 2-trans enoyl-ACP-reductase | - |
Mycobacterium tuberculosis |
| 1.3.1.9 | InhA | - |
Mycobacterium tuberculosis |
| EC Number | Cofactor | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.3.1.9 | NADH | - |
Mycobacterium tuberculosis |
| EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|---|
| 1.3.1.9 | 0.001 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(4-chlorophenoxy)-5-(1H-1,2,3-triazol-1-yl)phenol | |
| 1.3.1.9 | 0.001 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(4-chlorophenoxy)-5-[4-(1H-1,2,3-triazol-1-yl)butyl]phenol | |
| 1.3.1.9 | 0.00312 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(6-chloro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-phenylacetamide | |
| 1.3.1.9 | 0.004 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-(4-chlorophenoxy)-3-hydroxybenzonitrile | |
| 1.3.1.9 | 0.004 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(4-chlorophenoxy)-5-cyclohexylphenol | |
| 1.3.1.9 | 0.004 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(4-chlorophenoxy)-5-hexylphenol | |
| 1.3.1.9 | 0.00452 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(6-chloro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-[(furan-2-yl)methyl]acetamide | |
| 1.3.1.9 | 0.00456 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(6-chloro-4-oxoquinazolin-3(4H)-yl)-N-[2-chloro-5-(trifluoromethyl)phenyl]acetamide | |
| 1.3.1.9 | 0.00512 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-(6-nitro-1,3-benzothiazol-2-yl)-2-(4-oxoquinazolin-3(4H)-yl)acetamide | |
| 1.3.1.9 | 0.00778 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-(6-chloro-4-oxoquinazolin-3(4H)-yl)-N-phenylacetamide | |
| 1.3.1.9 | 0.008 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 4-(4-chlorophenoxy)[1,1'-biphenyl]-3-ol | |
| 1.3.1.9 | 0.0125 | - |
IC50 below 0.0125 mM, pH and temperature not specified in the publication | Mycobacterium tuberculosis | triclosan | |
| 1.3.1.9 | 0.0792 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | (2E)-3-[(4Z)-4-ethylidenecyclohexa-1,5-dien-1-yl]-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | |
| 1.3.1.9 | 0.099 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | (2E)-1-[4-(1H-pyrrol-1-yl)phenyl]-3-[4-(trifluoromethyl)phenyl]prop-2-en-1-one | |
| 1.3.1.9 | 0.198 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | (2E)-3-(4-methylphenyl)-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | |
| 1.3.1.9 | 0.198 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | (2E)-3-(6-fluorocyclohexa-1,5-dien-1-yl)-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one | |
| 1.3.1.9 | 0.2475 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | (2E)-3-(4-methoxyphenyl)-1-[4-(1H-pyrrol-1-yl)phenyl]prop-2-en-1-one |